news release

BURLINGTON, Mass.--(BUSINESS WIRE)--May 28, 2020-- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, chief executive officer, will present at the following investor conferences in June:

Jefferies Virtual Healthcare Conference
Presentation: Thursday, June 4, 2020 at 10:30 AM EDT

BMO’s Virtual 2020 Prescriptions for Success Healthcare Conference
Presentation: Tuesday, June 23, 2020 at 11:30 AM EDT

A live webcast of the presentations can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com, and will be archived for ninety days.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005127/en/

Katherine Taudvin, scPharmaceuticals Inc.
781-301-6706
ktaudvin@scpharma.com

Christopher F. Brinzey, Westwicke an ICR Company
339-970-2843
chris.brinzey@westwicke.com

Source: scPharmaceuticals Inc.